Together these data provide additional evidence for an epistatic relationship between TP53 and MDM2 in primary breast cancers, and highlight that complex conditional drug-gene interactions can be dissected in PDX using the UMI-encoded fitness approach. The gene discussed is TP53; the disease is breast cancer.